Table 1 Relative importance scores for each adverse event
From: Variability of the impact of adverse events on physicians’ decision making
Adverse events | Mean | Median | SD | Range |
|---|---|---|---|---|
Sepsis | 11.3 | 11.3 | 1.6 | 5.4-14.7 |
Serious infection | 11.0 | 11.3 | 2.1 | 4.0-14.8 |
Bone marrow suppression | 8.0 | 8.5 | 2.9 | 0.3-13.8 |
Opportunistic infection | 7.7 | 8.0 | 3.0 | 0.4-13.9 |
Lymphoma | 6.9 | 7.2 | 3.1 | 0.1-11.3 |
Malignancy | 6.7 | 7.7 | 3.5 | 0.1-13.1 |
Bladder cancer | 6.6 | 7.0 | 2.8 | 0.1-11.5 |
Serious infusion reaction | 5.8 | 5.7 | 3.8 | 0.1-13.7 |
Progressive multifocal leukoencephalopathy | 5.3 | 4.6 | 3.7 | 0.03-13.4 |
Myelodysplasia | 4.9 | 4.6 | 2.5 | 0.5-10.2 |
Hemorrhagic cystitis | 4.6 | 4.3 | 2.6 | 0.2-12.2 |
Hepatitis | 4.2 | 3.5 | 2.9 | 0.1-11.6 |
Myocardial damage | 3.4 | 3.1 | 2.6 | 0.1-11.1 |
Interstitial lung disease | 3.4 | 2.8 | 2.6 | 0.1-10.8 |
Leukopenia | 3.4 | 1.8 | 3.5 | 0.03-13.9 |
Serious skin reaction | 3.3 | 2.4 | 2.4 | 0.2-11.4 |
Zoster | 1.8 | 1.2 | 1.7 | 0.05-10.0 |
Mild infection | 0.5 | 0.1 | 1.1 | 0.004-6.7 |
Mucositis | 0.4 | 0.1 | 0.8 | 0.002-6.7 |
Alopecia | 0.2 | 0.03 | 0.4 | 0.0009-3.1 |
Nausea | 0.1 | 0.03 | 0.8 | 0.002-8.4 |
Mild infusion reaction | 0.06 | 0.02 | 0.1 | 0.001-0.5 |
Mild skin reaction | 0.05 | 0.009 | 0.2 | 0.0008-1.5 |